Innovation in Biological Indicator Evaluator Resistometer Vessel Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovation in Biological Indicator Evaluator Resistometer Vessel Technology
The authors examine advances in the design and the application of biological indicator evaluator resistometer vessels used to measure the resistance of bacterial spores in monitoring sterilization processes.


Pharmaceutical Technology


Sterilization deals with the destruction of microorganisms by exposing materials to conditions that are rapidly lethal to them. The validation of these processes generally relies on the use of resistant microorganisms termed biological indicators (BIs) that are positioned within the sterilizer. The destruction of these microorganisms during validation confirms the lethality of the process for the routine use of the sterilizer. Routine sterilization must be sufficiently lethal to the bioburden expected on or in the materials being processed. Information about the process resistance of both the BI and bioburden is essential to understanding process effectiveness. Over- or under-estimating the resistance of either the indicator or the indigenous bioburden can lead to failed validation studies, potentially contaminated batches, sterility failure investigations, and other serious situations.

Determination of microbial resistance

Determining microbial resistance once was only the concern of BI manufacturers and firms producing terminally sterilized products. There are several instances in which the firm using BIs could benefit by making its own resistance determination. These situations arise when either spore strips or suspension indicators are used as follows:

  • Spore strips are labeled by their manufacturer, with resistance based on their test methods and laboratory media. Differences in the methods and media at the end user's site can lead to altered resistance.
  • Suspensions of BIs come with a labeled resistance as well. That value is for the specific lot when tested as a spore strip. BI manufacturers caution their customers that these values may change when the indicator is inoculated onto a different substrate.
  • Elastomeric closures have been shown to alter the resistance of BI organisms dried on their surface as is currently expected in regulatory submissions
  • Resistance determination and screening of bioburden organisms can be detected in presterilization sampling
  • BI resistance is determined in support of cycle development, initial or revalidation of terminal sterilization processes
  • Sterility-test and media-fill failure investigations sometimes incorporate concerns regarding the resistance of presterilization bioburden organisms.

BIER vessels

BI evaluation resistometer (BIER) vessels have been used for more than 50 years to measure the resistance of bacterial spores when monitoring steam-sterilization processes. The earliest designs of steam-BIER vessels were developed by food-processing technologists, and were based on the concept of retorts used in the food-processing industry. These steam retorts maintained a large volume and constant flow of steam under pressure in an environment in which BI units were quickly inserted and removed. This process provided a nearly instantaneous come-up and cool-down condition for the exposed samples.

Medical and pharmaceutical technologists developed BIER vessels around conventional autoclave technology. The autoclave is a steam-pressure vessel in which materials are placed into a chamber at ambient pressure. The door is closed, steam is admitted into the chamber, and steady-state conditions are achieved. With specially engineered systems using very small chambers, the system can achieve nearly instantaneous come-up and cool-down conditions.

These special sterilizers were almost exclusively custom designed. Today, commercial units are offered by a limited number of manufacturers. The Fedegari system (model FOB 3, Fedegari Autoclavi SpA, Povia, Italy) tested in this study is a 140-L laboratory steam autoclave with an accessory attachment that allows rapid sample insertion into a chamber at steady-state conditions and rapid removal of the sample. The chamber's internal sample guide can be removed from the interior of the unit, thus allowing the unit to be used as a standard laboratory autoclave. This BIER vessel design can be used not only for BIs, but also for chemical indicators and process-challenge devices.


Figure 1: The BIER vessel's square-wave system. Samples placed in the BIER vessel are taken from ambient conditions, brought to the sterilizing condition, and returned to the ambient conditions.
The BIER vessel establishes a steady-state condition within a small sterilization chamber and relies on the rapid insertion and removal of samples for the conduct of the D-value determination. In its purest form, the BIER operates as a square wave system, in which the samples are instantaneously taken from ambient conditions, brought to the sterilizing condition, and returned to ambient conditions (see Figure 1). BIER-vessel standards for saturated steam mandate a maximum of 10 s for the come-up and come-down steps.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here